Switch to:

Regeneron Pharmaceuticals Price-to-Owner-Earnings

: 55.79 (As of Today)
View and export this data going back to 1991. Start your Free Trial

As of today (2020-08-03), Regeneron Pharmaceuticals's share price is $632.07. Regeneron Pharmaceuticals's Owner Earnings per Share (TTM) ended in Mar. 2020 was $11.33. It's Price-to-Owner-Earnings for today is 55.79.


NAS:REGN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 20.91   Med: 83.25   Max: 1511.41
Current: 55.8

20.91
1511.41

During the past 13 years, the highest Price-to-Owner-Earnings of Regeneron Pharmaceuticals was 1511.41. The lowest was 20.91. And the median was 83.25.


NAS:REGN's Price-to-Owner-Earnings is ranked lower than
52% of the 149 Companies
in the Biotechnology industry.

( Industry Median: 51.30 vs. NAS:REGN: 55.80 )

As of today (2020-08-03), Regeneron Pharmaceuticals's share price is $632.07. Regeneron Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2020 was $19.90. Therefore, Regeneron Pharmaceuticals's PE Ratio for today is 31.76.

As of today (2020-08-03), Regeneron Pharmaceuticals's share price is $632.07. Regeneron Pharmaceuticals's EPS without NRI for the trailing twelve months (TTM) ended in was $19.90. Therefore, Regeneron Pharmaceuticals's PE Ratio without NRI for today is 31.76.

During the past 13 years, Regeneron Pharmaceuticals's highest PE Ratio without NRI was 160.59. The lowest was 14.28. And the median was 44.77.


Regeneron Pharmaceuticals Price-to-Owner-Earnings Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Regeneron Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 103.62 72.40 105.05 30.69 26.44

Regeneron Pharmaceuticals Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.45 28.26 23.74 26.44 43.11

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Regeneron Pharmaceuticals Price-to-Owner-Earnings Distribution

* The bar in red indicates where Regeneron Pharmaceuticals's Price-to-Owner-Earnings falls into.



Regeneron Pharmaceuticals Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Regeneron Pharmaceuticals's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=632.07/11.33
=55.79

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Regeneron Pharmaceuticals  (NAS:REGN) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Regeneron Pharmaceuticals Price-to-Owner-Earnings Related Terms


Regeneron Pharmaceuticals Price-to-Owner-Earnings Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)